CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 122 enrolled
Drug / intervention
Oseltamivirdrug
Likely dose
Oseltamivir 75mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01249833
NCT01249833Phase 4Completed
CompareCT.gov

Randomised, Open-label, Multi-Centre, Phase IV Study Assessing the Effect of Oseltamivir Treatment on Cognitive Function in Subjects With Confirmed Influenza Virus Infection

Trial Management Group Inc.·interventional·Posted Nov 30, 2010·Updated Mar 9, 2017

In Brief

A Phase 4 clinical trial evaluating Oseltamivir for Influenza. Completed, enrolled 122 participants across 16 sites.

Detailed Summary

This study has been designed to determine if subjects treated with oseltamivir in addition to standard of care treatment for influenza demonstrate a greater improvement in attention / working memory / processing speed / mood as compared to subjects receiving standard of care alone. The cognitive tests employed are objective measures developed and administered online by HeadMinder Inc.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesCanada
CollaboratorsHoffmann-La Roche

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 30, 2010
Enrollment StartNov 1, 2010
Primary CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 15.6 years ago

Interventions

Oseltamivirdrug

Oseltamivir 75mg BID for 5 days